Eintrag weiter verarbeiten
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide
Gespeichert in:
Zeitschriftentitel: | Journal of International Medical Research |
---|---|
Personen und Körperschaften: | , , |
In: | Journal of International Medical Research, 12, 1984, 4, S. 255-260 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
SAGE Publications
|
Schlagwörter: |
author_facet |
Bruni, L Tagliapietra, G Innocenti, P Bruni, L Tagliapietra, G Innocenti, P |
---|---|
author |
Bruni, L Tagliapietra, G Innocenti, P |
spellingShingle |
Bruni, L Tagliapietra, G Innocenti, P Journal of International Medical Research Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide Biochemistry (medical) Cell Biology Biochemistry General Medicine |
author_sort |
bruni, l |
spelling |
Bruni, L Tagliapietra, G Innocenti, P 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/030006058401200406 <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p < 0·05), vesicles, crusts and burning sensation (p < 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p < 0·01 for pain; p < 0·05 for erythema) more than neuramide. </jats:p> Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide Journal of International Medical Research |
doi_str_mv |
10.1177/030006058401200406 |
facet_avail |
Online |
finc_class_facet |
Chemie und Pharmazie Biologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg0MDEyMDA0MDY |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg0MDEyMDA0MDY |
institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
imprint |
SAGE Publications, 1984 |
imprint_str_mv |
SAGE Publications, 1984 |
issn |
0300-0605 1473-2300 |
issn_str_mv |
0300-0605 1473-2300 |
language |
English |
mega_collection |
SAGE Publications (CrossRef) |
match_str |
bruni1984herpeszostertreatmentsresultsofaclinicaltrialrelativetotheuseofrifamycinsvversusneuramide |
publishDateSort |
1984 |
publisher |
SAGE Publications |
recordtype |
ai |
record_format |
ai |
series |
Journal of International Medical Research |
source_id |
49 |
title |
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_unstemmed |
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_full |
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_fullStr |
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_full_unstemmed |
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_short |
Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_sort |
herpes zoster treatments: results of a clinical trial relative to the use of rifamycin sv versus neuramide |
topic |
Biochemistry (medical) Cell Biology Biochemistry General Medicine |
url |
http://dx.doi.org/10.1177/030006058401200406 |
publishDate |
1984 |
physical |
255-260 |
description |
<jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p < 0·05), vesicles, crusts and burning sensation (p < 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p < 0·01 for pain; p < 0·05 for erythema) more than neuramide. </jats:p> |
container_issue |
4 |
container_start_page |
255 |
container_title |
Journal of International Medical Research |
container_volume |
12 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792325571010625542 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T12:07:42.714Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Herpes+Zoster+Treatments%3A+Results+of+a+Clinical+Trial+Relative+to+the+Use+of+Rifamycin+SV+versus+Neuramide&rft.date=1984-07-01&genre=article&issn=1473-2300&volume=12&issue=4&spage=255&epage=260&pages=255-260&jtitle=Journal+of+International+Medical+Research&atitle=Herpes+Zoster+Treatments%3A+Results+of+a+Clinical+Trial+Relative+to+the+Use+of+Rifamycin+SV+versus+Neuramide&aulast=Innocenti&aufirst=P&rft_id=info%3Adoi%2F10.1177%2F030006058401200406&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792325571010625542 |
author | Bruni, L, Tagliapietra, G, Innocenti, P |
author_facet | Bruni, L, Tagliapietra, G, Innocenti, P, Bruni, L, Tagliapietra, G, Innocenti, P |
author_sort | bruni, l |
container_issue | 4 |
container_start_page | 255 |
container_title | Journal of International Medical Research |
container_volume | 12 |
description | <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p < 0·05), vesicles, crusts and burning sensation (p < 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p < 0·01 for pain; p < 0·05 for erythema) more than neuramide. </jats:p> |
doi_str_mv | 10.1177/030006058401200406 |
facet_avail | Online |
finc_class_facet | Chemie und Pharmazie, Biologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg0MDEyMDA0MDY |
imprint | SAGE Publications, 1984 |
imprint_str_mv | SAGE Publications, 1984 |
institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
issn | 0300-0605, 1473-2300 |
issn_str_mv | 0300-0605, 1473-2300 |
language | English |
last_indexed | 2024-03-01T12:07:42.714Z |
match_str | bruni1984herpeszostertreatmentsresultsofaclinicaltrialrelativetotheuseofrifamycinsvversusneuramide |
mega_collection | SAGE Publications (CrossRef) |
physical | 255-260 |
publishDate | 1984 |
publishDateSort | 1984 |
publisher | SAGE Publications |
record_format | ai |
recordtype | ai |
series | Journal of International Medical Research |
source_id | 49 |
spelling | Bruni, L Tagliapietra, G Innocenti, P 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/030006058401200406 <jats:p> The authors describe a controlled clinical study in which rifamycin SV 250 mg intramuscularly and topical b.i.d. was compared to intramuscular neuramide b.i.d. plus, where necessary, other drugs (antibiotics, polivitamins, analgesics, etc.) for the treatment of two groups of thirty randomly selected patients suffering from herpes zoster. </jats:p><jats:p> In all patients the symptoms were controlled by both treatments but statistical tests revealed that rifamycin SV was able to heal pain (p < 0·05), vesicles, crusts and burning sensation (p < 0·1) faster than neuramide. </jats:p><jats:p> Furthermore, by the seventh day of therapy, the authors found that rifamycin SV reduced the intensity of both pain and erythema (p < 0·01 for pain; p < 0·05 for erythema) more than neuramide. </jats:p> Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide Journal of International Medical Research |
spellingShingle | Bruni, L, Tagliapietra, G, Innocenti, P, Journal of International Medical Research, Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide, Biochemistry (medical), Cell Biology, Biochemistry, General Medicine |
title | Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_full | Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_fullStr | Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_full_unstemmed | Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_short | Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
title_sort | herpes zoster treatments: results of a clinical trial relative to the use of rifamycin sv versus neuramide |
title_unstemmed | Herpes Zoster Treatments: Results of a Clinical Trial Relative to the Use of Rifamycin SV versus Neuramide |
topic | Biochemistry (medical), Cell Biology, Biochemistry, General Medicine |
url | http://dx.doi.org/10.1177/030006058401200406 |